Stereotaxis Inc (STXS)
2.05
+0.06
(+3.02%)
USD |
NYAM |
Sep 27, 16:00
2.03
-0.02
(-0.98%)
After-Hours: 20:00
Stereotaxis SG&A Expense (Annual): 26.43M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 26.43M |
December 31, 2022 | 26.69M |
December 31, 2021 | 25.92M |
December 31, 2020 | 17.54M |
December 31, 2019 | 18.57M |
December 31, 2018 | 17.87M |
December 31, 2017 | 19.61M |
December 31, 2016 | 25.57M |
December 31, 2015 | 26.39M |
December 31, 2014 | 27.01M |
December 31, 2013 | 30.20M |
December 31, 2012 | 34.00M |
Date | Value |
---|---|
December 31, 2011 | 48.54M |
December 31, 2010 | 45.20M |
December 31, 2009 | 43.70M |
December 31, 2008 | 49.78M |
December 31, 2007 | 47.72M |
December 31, 2006 | 39.18M |
December 31, 2005 | 30.56M |
December 31, 2004 | 17.28M |
December 31, 2003 | 11.37M |
December 31, 2002 | 7.176M |
December 31, 2001 | |
December 31, 2000 | 2.012M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
17.54M
Minimum
2020
26.69M
Maximum
2022
23.03M
Average
25.92M
Median
2021
SG&A Expense (Annual) Benchmarks
Axogen Inc | 121.00M |
SI-BONE Inc | 141.32M |
Cutera Inc | 176.32M |
Electromed Inc | 34.49M |
Myomo Inc | 18.78M |